SOPHiA GENETICS (SOPH) Share-based Compensation (2020 - 2025)

SOPHiA GENETICS has disclosed Share-based Compensation across 6 years of filings, most recently posting $3.9 million for Q4 2025.

• Share-based Compensation for Q4 2025 came in at $3.9 million, down 23.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $16.2 million (down 1.72% YoY), and the FY2025 annual result was $16.2 million, down 1.72% from the prior year.
• Share-based Compensation came in at $3.9 million for Q4 2025 at SOPHiA GENETICS, down from $4.1 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $5.1 million in Q4 2024 to a low of $639000.0 in Q1 2021.
• The 5-year median for Share-based Compensation is $3.8 million (2024), against an average of $3.5 million.
• Across the five-year window, Share-based Compensation surged 897.26% in 2021 and fell 29.99% in 2023, its largest moves.
• SOPHiA GENETICS's Share-based Compensation stood at $3.6 million in 2021, then declined by 28.68% to $2.6 million in 2022, then jumped by 62.21% to $4.2 million in 2023, then increased by 20.59% to $5.1 million in 2024, then declined by 23.83% to $3.9 million in 2025.
• The last three Share-based Compensation figures came in at $3.9 million (Q4 2025), $4.1 million (Q3 2025), and $4.4 million (Q2 2025), per Business Quant data.